Evidence map›Paper›PMID 33547084›Full record

ArticleScience advances2021

Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.

Ke Zhang, Lisa Miorin, Tadashi Makio, Ishmael Dehghan, Shengyan Gao, Yihu Xie, Hualin Zhong, Matthew Esparza, Thomas Kehrer, Anil Kumar and 9 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed
31.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 226 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Human coronaviruses: activation and antagonism of innate immune responses.Microbiology and molecular biology reviews : MMBR · 2025
    Review

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Ke ZhangDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-5365-3142
Lisa MiorinDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0003-0989-3178
Tadashi MakioDepartment of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Ishmael DehghanDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Shengyan GaoDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Yihu XieDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235, USA.
Hualin ZhongDepartment of Biological Sciences, Hunter College, New York, NY 10065, USA.
Matthew EsparzaDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-5277-0398
Thomas KehrerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-6433-0098
Anil KumarDepartment of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.ORCID 0000-0002-6179-4516
Tom C HobmanDepartment of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Christopher PtakDepartment of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Boning GaoNancy B. and Jake L. Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
John D MinnaNancy B. and Jake L. Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-7776-0767
Zhijian ChenDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-8475-8251
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-6551-1827
Yi RenDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235, USA.
Richard W WozniakDepartment of Cell Biology, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Beatriz M A FontouraDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. beatriz.fontoura@utsouthwestern.edu.ORCID 0000-0001-8468-5315
The University of Texas Southwestern Medical Center · USUniversity of Alberta · CAHoward Hughes Medical Institute · USIcahn School of Medicine at Mount Sinai · USVanderbilt University · USHunter College · USTisch Hospital · US

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V. · 1996 to 2024
$57.4M
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody AnalysesU54CA260560 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2020 to 2024
$10.0M
Virulence Factor at the Interface of Viral and Cellular mRNA Nuclear ExportR01AI154635 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Beatriz MA Fontoura · 2020 to 2026
$5.1M
Mechanisms and Regulation of Nuclear mRNA ExportR35GM133743 · NIGMS · VANDERBILT UNIVERSITY · PI Yi Ren · 2019 to 2026
$3.6M
NCI NIH HHS P50 CA070907NCI NIH HHS U54 CA260560NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI154635NIGMS NIH HHS R35 GM133743
6 · The paper itself

Abstract

The ongoing unprecedented severe acute respiratory syndrome caused by the SARS-CoV-2 outbreak worldwide has highlighted the need for understanding viral-host interactions involved in mechanisms of virulence. Here, we show that the virulence factor Nsp1 protein of SARS-CoV-2 interacts with the host messenger RNA (mRNA) export receptor heterodimer NXF1-NXT1, which is responsible for nuclear export of cellular mRNAs. Nsp1 prevents proper binding of NXF1 to mRNA export adaptors and NXF1 docking at the nuclear pore complex. As a result, a significant number of cellular mRNAs are retained in the nucleus during infection. Increased levels of NXF1 rescues the Nsp1-mediated mRNA export block and inhibits SARS-CoV-2 infection. Thus, antagonizing the Nsp1 inhibitory function on mRNA export may represent a strategy to restoring proper antiviral host gene expression in infected cells.

Indexed as

Gene ExpressionActive Transport, Cell NucleusAnimalsChlorocebus aethiopsCOVID-19HEK293 CellsHost Microbial InteractionsHumansNuclear PoreNucleocytoplasmic Transport ProteinsRNA-Binding ProteinsRNA, MessengerSARS-CoV-2TransfectionVero CellsViral Nonstructural ProteinsNucleocytoplasmic Transport ProteinsNXF1 protein, humanORF1ab polyprotein, SARS-CoV-2RNA-Binding ProteinsRNA, MessengerViral Nonstructural ProteinsVirulence Factors

Identifiers

PMID33547084
PMCPMC7864571
OpenAlexW3127173946

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.